CEMP

Cempra Inc

A clinical-stage pharmaceutical company that developed new antibiotics to treat serious bacterial infections, including lead candidates solithromycin and TAKSTA for conditions like pneumonia. Founded in 2006 in Chapel Hill, North Carolina by microbiologist Dr. Prabhavathi Fernandes, the firm worked on next-generation drugs to fight drug-resistant bugs. In 2017 it merged with Melinta Therapeutics and was absorbed under that name, closing the Cempra chapter.